Blog

Reporting to the IRB: What NOT to Report

December 11, 2019

Despite clarification from FDA and OHRP, many of the "potential" unanticipated event reports IRBs receive are either submitted unnecessarily or don't pertain to the aspects of research the IRB oversees.

Blog

Reporting to the IRB: Investigator Noncompliance

December 4, 2019

We often get questions about exactly what events should be reported to the IRB. We understand that “reportable events” can be tricky: some “events” are specifically referenced in the regulations,…

Blog

Making Sense of the New HUD Guidance

November 20, 2019

For almost a decade, the FDA guidance on humanitarian use devices (HUDs) dated July 8, 2010 has been the go-to document for industry, FDA staff, clinicians/users, and IRBs to understand…

Blog

Should Social Media Be Part of Your Research Toolbox?

November 12, 2019

Social media holds tremendous promise in the research sphere but requires sensitivity to pertinent regulatory and ethical considerations. Sponsors and investigators looking to incorporate social media into their research toolbox…

Blog

A Tale of Two Sites: The Power of Integrated Research Administration

October 23, 2019

Site timelines for studies can vary widely across the industry due to differences in internal efficiency. In this blog, James Riddle (Advarra VP of Institutional Services and Strategic Consulting) tells…

Blog

Reporting to the IRB: Unanticipated Device Effects (UADEs) in Medical Device Studies

October 2, 2019

In this blog, we’ll take a look at what the regulations do and do not say about IRB reporting requirements and how Advarra has addressed some of the undefined “gray…

Blog

How Centralized IBC Review Can Benefit Gene Therapy Research

September 18, 2019

Gene therapy research is at the forefront of a coming boom in the clinical setting. Understand the growth, risks, and regulatory requirements here.

Blog

Advarra Acquires Forte:
What You Need to Know

September 5, 2019

On September 5, 2019, Advarra announced its intent to acquire Forte. The combined organization leverages mutual strengths in supporting the research community with client service, regulatory expertise, and technology-enabled efficiencies…

Blog

Compensating Clinical Trial Participants: The Basics

August 28, 2019

Many clinical trial protocols include plans to compensate participants for their contribution to the research. According to FDA’s information sheet...

Blog

What Is a Screening Consent?

August 14, 2019

Informed consent is an ongoing process to ensure the participant has an initial and ongoing understanding of the research and its risks. In this blog, we’ll take a look at…